TCS to acquire Postbank Systems; stock opens lower
TCS to acquire Postbank Systems; stock opens lower

TCS to acquire Postbank Systems; stock opens lower

Rishikesh Gaikwad Article rating: 3.8

Tata Consultancy Services (TCS) and Deutsche Bank AG on Monday evening after the market hours announced an agreement, under which, TCS will acquire 100 per cent of the shares of Postbank Systems AG (PBS) from Deutsche Bank AG.

Dr Lal PathLabs reacts negatively to quarterly results; ends 1.63 per cent lower
Dr Lal PathLabs reacts negatively to quarterly results; ends 1.63 per cent lower

Dr Lal PathLabs reacts negatively to quarterly results; ends 1.63 per cent lower

Rishikesh Gaikwad Article rating: 2.4

Dr Lal PathLabs announced its financial results for quarter ending September 2020 today. Non-COVID business was back to 98 per cent of last year levels in Q2FY21. Revenue increased in Q2FY21 by 18.2 per cent to Rs 431.9 crore from Rs 365 crore last year during the same quarter.

Alembic Pharma receives one more ANDA
Alembic Pharma receives one more ANDA

Alembic Pharma receives one more ANDA

Rishikesh Gaikwad Article rating: 3.5

Alembic Pharmaceuticals Limited announced during the first half of the trading session (at around 10 am to be specific) that it has received tentative approval from United States Food & Drug Administration (USFDA) for its abbreviated new drug application (ANDA) Palbociclib capsules, 75 mg, 100 mg, and 125 mg. 

Firstsource Solutions partners with Uniphore; stock ends 1.45 per cent higher
Firstsource Solutions partners with Uniphore; stock ends 1.45 per cent higher

Firstsource Solutions partners with Uniphore; stock ends 1.45 per cent higher

Rishikesh Gaikwad Article rating: 2.8

Firstsource Solutions Limited today announced that it has partnered with Uniphore, the global leader in conversational service automation to utilise its platform as an important component to Firstsource’s Digitally Empowered Contact Center (DECC).

Tata Consultancy Services gains on partnering with B3i
Tata Consultancy Services gains on partnering with B3i

Tata Consultancy Services gains on partnering with B3i

Rishikesh Gaikwad Article rating: 4.5

Tata Consultancy Services (TCS) today announced its partnership with B3i Services AG to design, develop & launch ecosystem innovations based on distributed ledger technology (DLT) for the insurance industry.

Titan opens 1.47 per cent lower today after announcing Q2FY21 results
Titan opens 1.47 per cent lower today after announcing Q2FY21 results

Titan opens 1.47 per cent lower today after announcing Q2FY21 results

Rishikesh Gaikwad Article rating: 5.0

Titan Company Limited reported its Q2FY21 results on Wednesday. The main revenue contributor of the company is its jewellery segment. Hence, the streets always give heavy weightage for this segment’s performance. Its jewellery segment saw a reduction of 2.31 per cent in revenue from Rs 3,528 crore in Q2FY20 to Rs 3,446 crore this year. These numbers are excluding the bullion sales of Rs 391 crore.

TCS to help Volt in expanding payment offerings
TCS to help Volt in expanding payment offerings

TCS to help Volt in expanding payment offerings

Rishikesh Gaikwad Article rating: 5.0

Tata Consultancy Services (TCS) announced today that Volt has partnered with TCS to power Volt 2.0, its next-generation banking as a service (BaaS) platform. Volt is Australia's first neobank

Alembic Pharmaceuticals gets USFDA final approval for open-angle glaucoma drug
Alembic Pharmaceuticals gets USFDA final approval for open-angle glaucoma drug

Alembic Pharmaceuticals gets USFDA final approval for open-angle glaucoma drug

Rishikesh Gaikwad Article rating: 5.0

Alembic Pharmaceuticals Limited announced that it has received the final approval from US Food & Drug Administration (USFDA) for its abbreviated new drug application (ANDA) Timolol Maleate ophthalmic gel-forming solution, 0.25 per cent and 0.5 per cent.

RSS
1345678910Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR